The AI-focused pharmaceutical company’s Phase 2 trial of HARMONIC’s patient cohort experienced an 86 percent clinical benefit, which measures how the patient feels. The trial has a 43 percent ...

The player that DeJean replaced in the starting lineup at nickel, Avonte Maddox, is impressed as well. "He’s like a vet out there," Maddox said. "He knows where he’s supposed to be at.